Microplate Systems : Analysis of Potential Market Opportunity Worth USD 1,170 million by 2026
This report aims to provide detailed insights
into the global microplate systems
market. It provides valuable information on the type, procedure,
application, and region in the market. Furthermore, the information for these
segments, by region, is also presented in this report. Leading players in the
market are profiled to study their product offerings and understand the
strategies undertaken by them to be competitive in this market.
Revenue
Growth Analysis:
[270 Pages Report] The microplate systems market size is projected to reach USD 1,170 million by 2026 from
USD 927 million in 2021, at a CAGR of 4.8%.
Key Factors Driving Market Growth:
Growth of the market is driven
mainly by the increasing R&D expenditure in the pharmaceutical industry,
increasing focus on miniaturization, and the growing prevalence of diseases.
Download PDF
Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37081572
Growth in Pharmaceuticals and Biotechnology Industries:
In the last decade, the number of pharma companies
has grown significantly, especially in the emerging markets. As of 2019, there
are 1,131 publicly listed pharmaceutical and biotech companies across the Asia
Pacific, indicating a significant presence of local as well as international
players in the region.
According to the Pharmaceutical Research and Manufacturers Association (PhRMA),
US firms conduct a majority of the world’s R&D in pharmaceuticals and hold
the intellectual property rights to most new medicines. In addition, the
biopharmaceutical industry has developed over 5,000 new medicines around the
world, with ~3,400 compounds currently being studied in the US—more than in any
other region around the world.
Drug Discovery Application:
By application, the microplate systems
market is segmented drug discovery, clinical diagnostics, genomics and
proteomics research, and other applications. The drug discovery segment
accounted for the largest market share in 2020. The large share of this segment
can be attributed to The need for high-/ultra-high-throughput screening and
reduced time-to-market for drugs.
Regional Growth Analysis:
Based on the region, the microplate systems
market is segmented into North America, Europe, Asia Pacific, and the Rest of
the World (RoW). In 2020, North America accounted for the largest share of the
microplate systems market. The large share of North America can be attributed
to factors such as government initiatives for cell-based research, the
increasing acceptance of personalized medicine, increasing academic and
government investments in diagnostic research, and increasing focus on drug
discovery and development.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=37081572
Key Players:
Some of the major players operating in this market are Danaher Corporation
(US), Agilent Technologies Inc. (US), Thermo Fisher Scientific Inc.(US). In
2020, Danaher Corporation held the leading position in the market. The company
has a strong geographic presence across North America, Europe, and the Asia
Pacific. Moreover, the company’s strong brand recognition and comprehensive
product portfolio in the microplate system market is its key strength. Agilent
Technologies Inc.(US) held the second position in the microplate system market
in 2020.
Considering the current pandemic and the contribution of the pharmaceutical and
biotechnology industry in controlling the spread of the virus by providing
essential drugs, vaccines, kits, and other supplies, the demand for microplate
products is expected to increase in this industry.
Comments
Post a Comment